Autek China Inc. (SHE:300595)
China
· Delayed Price · Currency is CNY 16.23
+0.36 (2.27%)
Apr 1, 2025, 2:45 PM CST
Autek China Revenue
In the year 2024, Autek China had annual revenue of 1.81B CNY with 4.40% growth. Autek China had revenue of 382.62M in the quarter ending December 31, 2024, a decrease of -8.38%.
Revenue
1.81B
Revenue Growth
+4.40%
P/S Ratio
7.81
Revenue / Employee
561.66K
Employees
3,229
Market Cap
14.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
| Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
| Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
| Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
| Dec 31, 2020 | 870.66M | 223.76M | 34.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 26.00B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |